0.35Open0.35Pre Close3 Volume0 Open Interest1.00Strike Price105.00Turnover249.00%IV18.42%PremiumAug 16, 2024Expiry Date0.14Intrinsic Value100Multiplier24DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type0.7027Delta0.4665Gamma3.26Leverage Ratio-0.0053Theta0.0003Rho2.29Eff Leverage0.0010Vega
Cosmos Health Stock Discussion
Cosmos Health Inc., a diversified, vertically integrated global healthcare group, has made strides in expanding its contract manufacturing capabilities through its wholly-owned subsidiary, Cana Laboratories. The company recently announced a new agreement with Prov...
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
Cosmos Health (NASDAQ:COSM) announced that its subsidiary, Cana Laboratories, has secured additional contract manufacturing agreements with Provident Pharmaceuticals. The new orders include:
408,000 units of MIOREL for muscle spasms
222,000 units of CALCIFOLIN for nucleic acid synthesis
72,000 units...
Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market
Cosmos Health (NASDAQ:COSM) announced the successful completion of the pilot production and scale-up phases for its weight management solution, CCX0722, a biocompatible hydrogel. These milestones mark the end of the development phase, following earlier project updates such as the...
up up up to 1.60
No comment yet